NO962848L - Monohydrat av (E)-2'-deoksy-2'-(fluormetylen)cytidin - Google Patents

Monohydrat av (E)-2'-deoksy-2'-(fluormetylen)cytidin

Info

Publication number
NO962848L
NO962848L NO962848A NO962848A NO962848L NO 962848 L NO962848 L NO 962848L NO 962848 A NO962848 A NO 962848A NO 962848 A NO962848 A NO 962848A NO 962848 L NO962848 L NO 962848L
Authority
NO
Norway
Prior art keywords
fluoromethylene
cytidine
deoxy
monohydrate
neoplastic
Prior art date
Application number
NO962848A
Other languages
English (en)
Other versions
NO306409B1 (no
NO962848D0 (no
Inventor
Richard E Donaldson
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of NO962848D0 publication Critical patent/NO962848D0/no
Publication of NO962848L publication Critical patent/NO962848L/no
Publication of NO306409B1 publication Critical patent/NO306409B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO962848A 1994-01-07 1996-07-05 Monohydrat av (E)-2'-deoxy-2'-(fluormethylen)cytidin NO306409B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17895294A 1994-01-07 1994-01-07
PCT/US1994/014648 WO1995018815A1 (en) 1994-01-07 1994-12-13 Monohydrate of (e)-2'-deoxy-2'-(fluoromethylene)cytidine

Publications (3)

Publication Number Publication Date
NO962848D0 NO962848D0 (no) 1996-07-05
NO962848L true NO962848L (no) 1996-09-06
NO306409B1 NO306409B1 (no) 1999-11-01

Family

ID=22654587

Family Applications (1)

Application Number Title Priority Date Filing Date
NO962848A NO306409B1 (no) 1994-01-07 1996-07-05 Monohydrat av (E)-2'-deoxy-2'-(fluormethylen)cytidin

Country Status (20)

Country Link
EP (1) EP0738273B1 (no)
JP (1) JPH09511227A (no)
KR (1) KR100330328B1 (no)
CN (1) CN1043231C (no)
AT (1) ATE186732T1 (no)
AU (1) AU684604B2 (no)
CA (1) CA2179987C (no)
DE (1) DE69421721T2 (no)
DK (1) DK0738273T3 (no)
ES (1) ES2141330T3 (no)
FI (1) FI114396B (no)
GR (1) GR3032614T3 (no)
HU (1) HU217849B (no)
IL (1) IL112242A (no)
MX (1) MX9500363A (no)
NO (1) NO306409B1 (no)
NZ (1) NZ279030A (no)
TW (1) TW397838B (no)
WO (1) WO1995018815A1 (no)
ZA (1) ZA9512B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1043324B1 (en) 1997-11-12 2004-06-16 Mitsubishi Chemical Corporation Purine derivatives and medicine containing the same as the active ingredient
KR100747106B1 (ko) 1999-05-11 2007-08-08 미쯔비시 가가꾸 가부시끼가이샤 퓨린 유도체 이수화물, 이를 유효성분으로 함유하는 의약및 이의 제조 중간체

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2002648C (en) * 1988-11-15 2000-02-29 James R. Mccarthy 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives
FI95269C (fi) * 1989-05-15 1996-01-10 Squibb Bristol Myers Co 2',3'-dideoksi-inosiinimonohydraatin, 2',3'-dideoksi-2',3'-didehydrot ymidiinimonohydraatin ja 2',3'-dideoksi-2'-fluori-inosiinihemihydraatin antiviraalisia, hyvin vesiliukoisia, stabiileja, kiteisiä suoloja
JPH0615557B2 (ja) * 1990-02-19 1994-03-02 ヤマサ醤油株式会社 ２’―デオキシ―２’―メチリデンシチジンの２水和物結晶
JP3265548B2 (ja) * 1992-05-12 2002-03-11 メレルファーマス−ティカルズ インコーポレイテッド リボヌクレオチド還元酵素阻害剤の製法

Also Published As

Publication number Publication date
GR3032614T3 (en) 2000-05-31
TW397838B (en) 2000-07-11
NZ279030A (en) 1997-05-26
DE69421721D1 (de) 1999-12-23
IL112242A (en) 2000-08-31
HUT75055A (en) 1997-03-28
WO1995018815A1 (en) 1995-07-13
CA2179987C (en) 1999-01-19
DE69421721T2 (de) 2000-04-27
AU684604B2 (en) 1997-12-18
NO306409B1 (no) 1999-11-01
IL112242A0 (en) 1995-03-30
FI114396B (fi) 2004-10-15
JPH09511227A (ja) 1997-11-11
NO962848D0 (no) 1996-07-05
HU9601848D0 (en) 1996-09-30
ES2141330T3 (es) 2000-03-16
CN1043231C (zh) 1999-05-05
FI962769A0 (fi) 1996-07-05
CN1141045A (zh) 1997-01-22
AU1553295A (en) 1995-08-01
ATE186732T1 (de) 1999-12-15
MX9500363A (es) 1998-04-30
HU217849B (hu) 2000-04-28
FI962769A (fi) 1996-07-05
DK0738273T3 (da) 2000-04-17
EP0738273B1 (en) 1999-11-17
EP0738273A1 (en) 1996-10-23
ZA9512B (en) 1995-09-11
KR100330328B1 (ko) 2002-12-05
CA2179987A1 (en) 1995-07-13

Similar Documents

Publication Publication Date Title
BR9811121A (pt) Produto, composição farmacêutica, e uso de um produto
CA2002648A1 (en) 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives
SE9500566D0 (sv) L-plate
PT755249E (pt) Utilizacao de inibidores da reaccao de maillard para o tratamento de doenca com base em amiloidose
ES2191292T3 (es) Compuestos antivirales poliaromaticos.
IE893080L (en) Novel 2'-halomethylidene,2'-ethenylidene and¹2'-ethynyl adenosine derivatives
EP0347852A3 (en) Novel neplanocin derivatives
DK0750616T3 (da) Syreadditionssalte af 2,3,4,5-tetrahydro-1H-3-benzazapinforbindelser
MY124071A (en) Treatment of viral disease in swine
NO306409B1 (no) Monohydrat av (E)-2'-deoxy-2'-(fluormethylen)cytidin
BR9811643A (pt) Suplementação quìmica de osso
BR9916043A (pt) Composto, uso do mesmo e de seus saisfarmaceuticamente aceitáveis, e, composiçãofarmacêutica para tratamento de infecções deherpes viral em pacientes
DE69836087D1 (de) Kortikalknochenimplantat für wirbelfusion nach smith-robinson
TR199802200A2 (xx) S�lfonamid s�bstit�e edilmi� benzopiran t�revleri, �retilme y�ntemi.
DK0459176T3 (da) Oligophosphater med antiviral virkning
GR3034688T3 (en) Use of 6,7-substituted-2-aminotetralines for preparing pharmaceutical compositions useful for the treatment of septic shock, and antipyretic and antiinflammatory pharmaceutical compositions
BR0012380A (pt) 2-amino-benzoxazinonas para o tratamento de vìrus do herpes simples
SE9403861D0 (sv) Novel medicinal use
AR015724A1 (es) La utilizacion de un inhibidor del intercambiador entre na+ y h+ para la preparacion de un medicamento destinado al tratamiento o a la profilaxia deenfermedades del sistema nervioso central.
ES2181160T3 (es) Derivados de 1,4-dihidropiridina y su utilizacion en terapia.
LTIP1943A (en) Arylating agents, used in the treatment of cancerand disease caused by viral infection
BR9906931A (pt) Triazepinonas, processo para sua preparação e sua aplicação terapêutica
DE69407180T2 (de) Fluoro-nukleosid-reinigung
ITCA950008A0 (it) Impiego di combinaqzioni di analoghi di nucleosidi nella terapia delleinfezioni dell'aids.
UA22189A (uk) Іі-кабетоксифеhілакоhітімід, який виявляє активhість відhосhо вірусу везикулярhого стоматиту та вірусу простого герпесу